A citation-based method for searching scientific literature

Susan Morand, Monika Devanaboyina, Hannah Staats, Laura Stanbery, John Nemunaitis. Int J Mol Sci 2021
Times Cited: 3







List of co-cited articles
3 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells.
Taiwen Li, Jingyu Fan, Binbin Wang, Nicole Traugh, Qianming Chen, Jun S Liu, Bo Li, X Shirley Liu. Cancer Res 2017
66

GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis.
Zefang Tang, Boxi Kang, Chenwei Li, Tianxiang Chen, Zemin Zhang. Nucleic Acids Res 2019
849
66

Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer.
Minghai Zhang, Shanshan Cheng, Yue Jin, Yaqian Zhao, Yu Wang. Biochim Biophys Acta Rev Cancer 2021
11
66

clusterProfiler: an R package for comparing biological themes among gene clusters.
Guangchuang Yu, Li-Gen Wang, Yanyan Han, Qing-Yu He. OMICS 2012
33

Cocktail strategy for 'cold' tumors therapy via active recruitment of CD8+ T cells and enhancing their function.
Xiang Li, Lihua Luo, Mengshi Jiang, Chunqi Zhu, Yingying Shi, Junlei Zhang, Bing Qin, Zhenyu Luo, Xuemeng Guo, Yichao Lu,[...]. J Control Release 2021
5
33

Inhibition of CXCR2 plays a pivotal role in re-sensitizing ovarian cancer to cisplatin treatment.
Taciane Barbosa Henriques, Diandra Zipinotti Dos Santos, Isabella Dos Santos Guimarães, Nayara Gusmão Tessarollo, Paulo Cilas Morais Lyra-Junior, Patricia Mesquita, Diana Pádua, Ana Luisa Amaral, Bruno Cavadas, Luisa Pereira,[...]. Aging (Albany NY) 2021
2
50

m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells.
Liang Hao, Jia-Mei Wang, Bao-Qin Liu, Jing Yan, Chao Li, Jing-Yi Jiang, Fu-Ying Zhao, Huai-Yu Qiao, Hua-Qin Wang. Biochim Biophys Acta Mol Cell Res 2021
26
33

Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden.
Zachary R Chalmers, Caitlin F Connelly, David Fabrizio, Laurie Gay, Siraj M Ali, Riley Ennis, Alexa Schrock, Brittany Campbell, Adam Shlien, Juliann Chmielecki,[...]. Genome Med 2017
33

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
Ethan Cerami, Jianjiong Gao, Ugur Dogrusoz, Benjamin E Gross, Selcuk Onur Sumer, Bülent Arman Aksoy, Anders Jacobsen, Caitlin J Byrne, Michael L Heuer, Erik Larsson,[...]. Cancer Discov 2012
33

Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.
Fangjun Chen, Zhengyun Zou, Juan Du, Shu Su, Jie Shao, Fanyan Meng, Ju Yang, Qiuping Xu, Naiqing Ding, Yang Yang,[...]. J Clin Invest 2019
76
33

Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance.
Abir Mukherjee, Chun-Yi Chiang, Helen A Daifotis, Kristin M Nieman, Johannes F Fahrmann, Ricardo R Lastra, Iris L Romero, Oliver Fiehn, Ernst Lengyel. Cancer Res 2020
38
33

CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis.
Gong Yang, Daniel G Rosen, Guangzhi Liu, Fan Yang, Xiaoqing Guo, Xue Xiao, Fengxia Xue, Imelda Mercado-Uribe, Jiaoti Huang, Sue-Hwa Lin,[...]. Clin Cancer Res 2010
119
33

Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data.
Francesca Finotello, Clemens Mayer, Christina Plattner, Gerhard Laschober, Dietmar Rieder, Hubert Hackl, Anne Krogsdam, Zuzana Loncova, Wilfried Posch, Doris Wilflingseder,[...]. Genome Med 2019
215
33

CXCR2-modified CAR-T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma.
Guangna Liu, Wei Rui, Hongli Zheng, Daosheng Huang, Fei Yu, Yuewei Zhang, Jiahong Dong, Xueqiang Zhao, Xin Lin. Eur J Immunol 2020
57
33

A C-X-C Chemokine Receptor Type 2-Dominated Cross-talk between Tumor Cells and Macrophages Drives Gastric Cancer Metastasis.
Zhijun Zhou, Guanggai Xia, Zhen Xiang, Mingyang Liu, Zhewei Wei, Jie Yan, Wei Chen, Jintao Zhu, Niranjan Awasthi, Xiaotian Sun,[...]. Clin Cancer Res 2019
39
33

Macrophage-mediated vascular permeability via VLA4/VCAM1 pathway dictates ascites development in ovarian cancer.
Shibo Zhang, Bingfan Xie, Lijie Wang, Hua Yang, Haopei Zhang, Yuming Chen, Feng Wang, Changqing Liu, Huanhuan He. J Clin Invest 2021
7
33

Chemokine Receptor CXCR-2 Initiates Atrial Fibrillation by Triggering Monocyte Mobilization in Mice.
Yun-Long Zhang, Hua-Jun Cao, Xiao Han, Fei Teng, Chen Chen, Jie Yang, Xiao Yan, Pang-Bo Li, Ying Liu, Yun-Long Xia,[...]. Hypertension 2020
12
33


Molecular signatures database (MSigDB) 3.0.
Arthur Liberzon, Aravind Subramanian, Reid Pinchback, Helga Thorvaldsdóttir, Pablo Tamayo, Jill P Mesirov. Bioinformatics 2011
33

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
Aravind Subramanian, Pablo Tamayo, Vamsi K Mootha, Sayan Mukherjee, Benjamin L Ebert, Michael A Gillette, Amanda Paulovich, Scott L Pomeroy, Todd R Golub, Eric S Lander,[...]. Proc Natl Acad Sci U S A 2005
33


xCell: digitally portraying the tissue cellular heterogeneity landscape.
Dvir Aran, Zicheng Hu, Atul J Butte. Genome Biol 2017
952
33

Classification and characterization of microsatellite instability across 18 cancer types.
Ronald J Hause, Colin C Pritchard, Jay Shendure, Stephen J Salipante. Nat Med 2016
388
33

Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases.
Yuan Cheng, Xue-Lei Ma, Yu-Quan Wei, Xia-Wei Wei. Biochim Biophys Acta Rev Cancer 2019
99
33

The NCI Genomic Data Commons as an engine for precision medicine.
Mark A Jensen, Vincent Ferretti, Robert L Grossman, Louis M Staudt. Blood 2017
111
33

Maftools: efficient and comprehensive analysis of somatic variants in cancer.
Anand Mayakonda, De-Chen Lin, Yassen Assenov, Christoph Plass, H Phillip Koeffler. Genome Res 2018
808
33

CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target.
Wen Zhang, Huishan Wang, Mingyang Sun, Xueting Deng, Xueru Wu, Yilan Ma, Mengjing Li, Said Maisam Shuoa, Qiang You, Lin Miao. Cancer Commun (Lond) 2020
37
33

Autophagic adaptation to oxidative stress alters peritoneal residential macrophage survival and ovarian cancer metastasis.
Houjun Xia, Shasha Li, Xiong Li, Weichao Wang, Yingjie Bian, Shuang Wei, Sara Grove, Weimin Wang, Linda Vatan, J Rebecca Liu,[...]. JCI Insight 2020
23
33


Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy.
Suzanne L Topalian, Janis M Taube, Robert A Anders, Drew M Pardoll. Nat Rev Cancer 2016
33

Re-education of Tumor-Associated Macrophages by CXCR2 Blockade Drives Senescence and Tumor Inhibition in Advanced Prostate Cancer.
Diletta Di Mitri, Michela Mirenda, Jelena Vasilevska, Arianna Calcinotto, Nicolas Delaleu, Ajinkya Revandkar, Veronica Gil, Gunther Boysen, Marco Losa, Simone Mosole,[...]. Cell Rep 2019
59
33



limma powers differential expression analyses for RNA-sequencing and microarray studies.
Matthew E Ritchie, Belinda Phipson, Di Wu, Yifang Hu, Charity W Law, Wei Shi, Gordon K Smyth. Nucleic Acids Res 2015
33

CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity.
Álvaro Teijeira, Saray Garasa, María Gato, Carlos Alfaro, Itziar Migueliz, Assunta Cirella, Carlos de Andrea, Maria Carmen Ochoa, Itziar Otano, Iñaki Etxeberria,[...]. Immunity 2020
146
33

Targeting tumor microenvironment in ovarian cancer: Premise and promise.
Yuting Jiang, Chengdi Wang, Shengtao Zhou. Biochim Biophys Acta Rev Cancer 2020
34
33

ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer.
R E Miller, A Leary, C L Scott, V Serra, C J Lord, D Bowtell, D K Chang, D W Garsed, J Jonkers, J A Ledermann,[...]. Ann Oncol 2020
69
33

Current Ovarian Cancer Maintenance Strategies and Promising New Developments.
Vinaya Gogineni, Susan Morand, Hannah Staats, Rachel Royfman, Monika Devanaboyina, Katelyn Einloth, Danielle Dever, Laura Stanbery, Phylicia Aaron, Luisa Manning,[...]. J Cancer 2021
10
33

Optimal first-line treatment in ovarian cancer.
F A Raja, N Chopra, J A Ledermann. Ann Oncol 2012
80
33

Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis.
Yinu Wang, Guangyuan Zhao, Salvatore Condello, Hao Huang, Horacio Cardenas, Edward J Tanner, JianJun Wei, Yanrong Ji, Junjie Li, Yuying Tan,[...]. Cancer Res 2021
25
33

DGAT1 Expression Promotes Ovarian Cancer Progression and Is Associated with Poor Prognosis.
Leilei Xia, Ye Wang, Shengyun Cai, Mingjuan Xu. J Immunol Res 2021
6
33

Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma.
Timothy M Nywening, Brian A Belt, Darren R Cullinan, Roheena Z Panni, Booyeon J Han, Dominic E Sanford, Ryan C Jacobs, Jian Ye, Ankit A Patel, William E Gillanders,[...]. Gut 2018
186
33

Targeted Deletion of CXCR2 in Myeloid Cells Alters the Tumor Immune Environment to Improve Antitumor Immunity.
Jinming Yang, Chi Yan, Anna E Vilgelm, Sheau-Chiann Chen, Gregory D Ayers, Christopher A Johnson, Ann Richmond. Cancer Immunol Res 2021
16
33

Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics.
Dongbin Yang, Weihong Zhang, Huanyun Zhang, Fengqiu Zhang, Lanmei Chen, Lixia Ma, Leon M Larcher, Suxiang Chen, Nan Liu, Qingxia Zhao,[...]. Theranostics 2020
151
33

Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.
Pinar Kanlikilicer, Recep Bayraktar, Merve Denizli, Mohammed H Rashed, Cristina Ivan, Burcu Aslan, Rahul Mitra, Kubra Karagoz, Emine Bayraktar, Xinna Zhang,[...]. EBioMedicine 2018
95
33

Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
Ruifen Wang, Yeqi Sun, Wenwei Yu, Yu Yan, Meng Qiao, Ruiqi Jiang, Wenbin Guan, Lifeng Wang. J Exp Clin Cancer Res 2019
72
33

Expression and molecular profiles of the AlkB family in ovarian serous carcinoma.
Yuan Cai, Geting Wu, Bi Peng, Juanni Li, Shuangshuang Zeng, Yuanliang Yan, Zhijie Xu. Aging (Albany NY) 2021
9
33

CTLA-4: a moving target in immunotherapy.
Behzad Rowshanravan, Neil Halliday, David M Sansom. Blood 2018
310
33

FGF9 induces functional differentiation to Schwann cells from human adipose derived stem cells.
Chia-Wei Huang, Shih-Yu Lu, Tzu-Chieh Huang, Bu-Miim Huang, H Sunny Sun, Shang-Hsun Yang, Jih-Ing Chuang, Yuan-Yu Hsueh, Yi-Ting Wu, Chia-Ching Wu. Theranostics 2020
8
33

FGF9 inhibition by a novel binding peptide has efficacy in gastric and bladder cancer per se and reverses resistance to cisplatin.
Jizhong Wang, Xiangpeng Tan, Qiuxiao Guo, Xiaomian Lin, Yishan Huang, Liankuai Chen, Xiangfeng Zeng, Rongzhen Li, Heng Wang, Xiaoping Wu. Pharmacol Res 2020
4
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.